These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11722677)

  • 1. DNA topoisomerases as targets for anticancer drugs.
    Topcu Z
    J Clin Pharm Ther; 2001 Dec; 26(6):405-16. PubMed ID: 11722677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
    Tse-Dinh YC
    Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects.
    Boege F
    Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):873-88. PubMed ID: 8960461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of eukaryotic topoisomerases to DNA damage.
    Kingma PS; Osheroff N
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):223-32. PubMed ID: 9748592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA.
    Nitiss JL; Wang JC
    Mol Pharmacol; 1996 Nov; 50(5):1095-102. PubMed ID: 8913340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy.
    You F; Gao C
    Curr Top Med Chem; 2019; 19(9):713-729. PubMed ID: 30931860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
    Saleem A; Ibrahim N; Patel M; Li XG; Gupta E; Mendoza J; Pantazis P; Rubin EH
    Cancer Res; 1997 Nov; 57(22):5100-6. PubMed ID: 9371509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to topoisomerases poisons.
    Prost S
    Gen Pharmacol; 1995 Dec; 26(8):1773-84. PubMed ID: 8745168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
    Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase inhibitors as anticancer agents: a patent update.
    Khadka DB; Cho WJ
    Expert Opin Ther Pat; 2013 Aug; 23(8):1033-56. PubMed ID: 23611704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs.
    Shen LL; Baranowski J; Fostel J; Montgomery DA; Lartey PA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2778-84. PubMed ID: 1336349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA topoisomerases from Streptomyces noursei: influence of coumarins and quinolones on the enzymic activity.
    Störl K; Störl J; Roth M; Zimmer C
    Biochim Biophys Acta; 1994 Mar; 1199(2):143-8. PubMed ID: 8123663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy.
    Wang JC
    NCI Monogr; 1987; (4):3-6. PubMed ID: 2819727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerases, new targets in cancer chemotherapy.
    Zijlstra JG; de Jong S; de Vries EG; Mulder NH
    Med Oncol Tumor Pharmacother; 1990; 7(1):11-8. PubMed ID: 2160032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA topoisomerases and topoisomerase inhibitors.
    Giaccone G
    Pathol Biol (Paris); 1994 Apr; 42(4):346-52. PubMed ID: 7808789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.
    Baglini E; Salerno S; Barresi E; Robello M; Da Settimo F; Taliani S; Marini AM
    Eur J Pharm Sci; 2021 Jan; 156():105594. PubMed ID: 33059042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
    Thielmann HW; Popanda O; Gersbach H; Gilberg F
    Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aclacinomycin A stabilizes topoisomerase I covalent complexes.
    Nitiss JL; Pourquier P; Pommier Y
    Cancer Res; 1997 Oct; 57(20):4564-9. PubMed ID: 9377570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.